IDOX (IDOX) Trading Update summary
Event summary combining transcript, slides, and related documents.
Trading Update summary
6 Jun, 2025Trading performance and outlook
Trading in the period from 1 November 2024 has met expectations for increased revenue and adjusted EBITDA, with net debt reduction anticipated for FY25.
New contract wins and extensions across all business areas support confidence in further progress for FY25.
Strong future pipeline visibility and investments in people and technology position the business for growth, especially in geospatial and core divisions.
Significant financial resources enable the pursuit of larger, accretive, and technology-enhancing acquisitions.
Strategic focus and management commentary
Emphasis on securing high-quality recurring revenue and repeatable services to underpin growth.
Management remains aware of political and economic uncertainties but is confident in the company's positioning.
The balance sheet remains strong, supporting further value-enhancing M&A activity.
Future updates and company information
A further trading update will be provided after the half year ending 30 April 2025.
Idox continues to focus on scaling through acquisitions and leveraging its financial strength.
Latest events from IDOX
- Revenue and Adjusted EBITDA rose, with a recommended takeover offer in progress.IDOX
H2 202517 Feb 2026 - Revenue up 21% to £43.1m, recurring revenue up 29%, outlook and cash generation strong.IDOX
H1 20241 Feb 2026 - Revenue up 20%, strong cash flow, and geospatial focus drive growth and margin expansion.IDOX
H2 20249 Jan 2026 - Revenue, EBITDA, and order intake rose, with recurring revenue now 66% of total.IDOX
H1 202513 Nov 2025 - Idox achieved 20% revenue growth and strengthened its geospatial offering with Emapsite.IDOX
Trading Update13 Jun 2025 - Revenue, EBITDA, and order intake rose in HY25, with a strengthened Social Care portfolio.IDOX
Trading Update6 Jun 2025